UBS Group AG trimmed its position in Rxo Inc (NYSE:RXO – Free Report) by 29.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,519,650 shares of the company’s stock after selling 640,257 shares during the quarter. UBS Group AG’s holdings in RXO were worth $19,208,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in RXO. Vanguard Group Inc. boosted its position in shares of RXO by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 17,309,811 shares of the company’s stock worth $218,796,000 after purchasing an additional 93,130 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of RXO by 50.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 46,091 shares of the company’s stock valued at $583,000 after purchasing an additional 15,408 shares during the last quarter. Cornerstone Wealth Group LLC boosted its stake in RXO by 5.1% in the 4th quarter. Cornerstone Wealth Group LLC now owns 275,066 shares of the company’s stock worth $3,477,000 after purchasing an additional 13,298 shares in the last quarter. Patten Group Inc. purchased a new stake in RXO during the 4th quarter worth approximately $404,000. Finally, Tectonic Advisors LLC grew its position in RXO by 11.7% during the 4th quarter. Tectonic Advisors LLC now owns 70,372 shares of the company’s stock worth $890,000 after purchasing an additional 7,350 shares during the last quarter. 92.73% of the stock is owned by institutional investors and hedge funds.
RXO Stock Down 4.9%
Shares of RXO stock opened at $20.70 on Tuesday. Rxo Inc has a twelve month low of $10.43 and a twelve month high of $23.37. The stock has a market cap of $3.41 billion, a P/E ratio of -33.93, a P/E/G ratio of 32.97 and a beta of 1.96. The stock has a 50 day moving average of $16.20 and a 200 day moving average of $15.05. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28.
Wall Street Analyst Weigh In
A number of research firms have issued reports on RXO. Benchmark reaffirmed a “hold” rating on shares of RXO in a report on Monday, February 9th. Stifel Nicolaus set a $15.00 target price on RXO in a research note on Thursday, February 5th. UBS Group boosted their price target on RXO from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday. Citigroup increased their price objective on RXO from $17.00 to $24.00 and gave the company a “neutral” rating in a report on Friday. Finally, Wall Street Zen upgraded RXO from a “sell” rating to a “hold” rating in a research note on Saturday. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $19.54.
Get Our Latest Stock Report on RXO
RXO Company Profile
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Recommended Stories
- Five stocks we like better than RXO
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
